Clinical Trial: A Phase I/II of HRS-6719 in Patients With Advanced/Metastatic Solid Tumors

U.S., April 11 -- ClinicalTrials.gov registry received information related to the study (NCT06922357) titled 'A Phase I/II of HRS-6719 in Patients With Advanced/Metastatic Solid Tumors' on April 03.

Brief Summary: This is a Phase I/II, multicenter, open-label clinical trial with dose escalation/dose expansion/efficacy expansion phases, designed to evaluate the safety, tolerability, pharmacokinetic/pharmacodynamic (PK/PD) profiles, and antitumor efficacy characteristics of HRS-6719 in patients with MTAP-deficient advanced solid tumors.

Study Start Date: April, 2025

Study Type: INTERVENTIONAL

Condition: Advanced/Metastatic Solid Tumors

Intervention: DRUG: HRS-6719

HRS-6719

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Shandong Sun...